Clinical decision support
Latest studies have demonstrated high AI accuracies in predicting cancer recurrence and spotting minor colon polyps.
It is now being tested at Princess Alexandra Hospital in Brisbane.
The app has demonstrated 93% accuracy in a nationwide study involving nearly 1,800 seniors.
The company said it plans to expand U.S. access to its services while growing its pipeline to include additional cardiac conditions and new distribution channels.
Also, OMRON in Singapore has launched a new medical device plan featuring AI-driven recommendations for self-management of chronic diseases.
While commercial software is very good at providing clinical decision support applications, it is essential to identify a targeted goal within the software, says Dr. Ryan Sadeghian, CMIO at the University of Toledo.
The AI co-developed with ASX-listed Artrya can outperform the Agatston score in predicting cardiac events.
It can also predict the onset of Parkinson's motor symptoms.
Also, four tuberculosis screening AI solutions from Asia-Pacific are among those recommended by the World Health Organization.
In a panel discussion, IT professionals and health system executives discussed the challenges of implementing AI across diverse healthcare settings.